Todos Med (OTCMKTS:TOMDF) and Aclarion (NASDAQ:ACON) Head-To-Head Survey
Reviewing Todos Med (OTCMKTS:TOMDF) & Auna (NYSE:AUNA)
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
Todos Medical Announces Insolvency Proceedings in Israel
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
Todos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic test
Todos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patients
Todos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rollout
Todos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humans
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference
Todos Medical signs agreement to sell supplements via Affy Services' Smart Automated Retail Network
Todos Medical finds major 3Q revenue bump from COVID-19 testing services
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
Todos Medical clinical laboratory Provista Diagnostics submits emergency use application for its PCR monkeypox test
Todos Medical pursuing New York Stock Exchange listing, it says in a wide-ranging update into new business developments
Todos Medical touts successful pilot launch of suite of PCR testing services by its lab Provista Diagnostics
Todos Medical set to be granted two patents for its TBIA pan-cancer blood diagnostics platform
Todos Medical announces receipt of notice of allowance for its 3CL protease biomarker diagnostics TolloTest
Todos Medical strikes $50M contact with Nerd Hemp to distribute Tollovid and CBD products in AI retail machines across the US
Todos Medical announces NFL Hall of Famer Michael Irvin as Tollovid Sports Ambassador for #TolloUp campaign
Todos Medical initiates validation plan for PCR-based polio testing at its Provista Diagnostics laboratory
Todos Medical partner NLC Pharma assigns IP for Tollovir, Tollovid, and TolloTest to joint venture 3CL Pharma
Todos Medical inks lease deal on botanical supplement manufacturing facility in Texas to produce Tollovid
Todos Medical expands COVID onsite school sample collection to include MonkeyPox
Todos Medical says it's Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics is now offering saliva-only MonkeyPox testing
Todos Medical reports rise in 2Q revenue, initiates Monkeypox diagnostic case study series
Todos Medical reports rise in 2Q revenue
Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
Todos Medical says Provista Diagnostics subsidiary has commercially launched PCR-based MonkeyPox testing in the US
Todos Medical says 3CL Pharma subsidiary completes trial design for Tollovid Long COVID clinical study in adults
Todos Medical completes trial design for Tollovid Long COVID clinical study in adults
Todos Medical says Provista Diagnostics lab finishes validation of Wound and Respiratory Pathogen panels; plans to add monkeypox testing
Todos Medical says Provista Diagnostics to provide PCR-based monkeypox testing for clients in New Jersey
Todos Medical wins first lab services contract for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
Todos Medical poised to branch into MonkeyPox testing as Provista Diagnostics begins validation plan
Todos Medical says new study highlights case for use of dietary supplement product Tollovid
Todos Medical partners with Amerimmune Diagnostics on long-COVID biomarker panel
Todos Medical and 3CL Pharma hail return to better health in long COVID case through use of Tollovid
Todos Medical plans open label extension of Phase 2 trial of Tollovir in hospitalized Covid patients after encouraging biomarker data
Todos Medical reveals promising data from sponsored study of dietary supplement Tollovid in respondents with COVID-19
Todos Medical says lab Provista to launch UTI pathogen PCR assay commercially
Todos Medical reports that long COVID patient felt "90 to 95% better" within five days of taking 3CL protease inhibitor dietary supplement Tollovid
Todos Medical to Present at The LD Micro Conference
Todos Medical academic partner fully enrolls second cohort of LymPro Alzheimer's Blood Test trial
Todos Medical says dietary supplement Tollovid has beneficial effect in long COVID case study after 26 days
Todos Medical updates investors on its lab Provista Diagnostics, its 3CL Pharma subsidiary, and its plans to uplist onto a major stock exchange
Todos Medical says unit will present final data from Tollovir Phase 2 clinical trial in hospitalized coronavirus patients at PMWC
Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World Conference
Todos Medical reports dietary supplement 'excellent rescue agent' for Long COVID patient in case study following Paxlovid treatment